drugset / Trial / NCT07279493
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a multicenter, randomized, double-blind, parallel, placebo-controlled trial design to evaluate the efficacy and safety of the KPCXM18 injection at different doses for the treatment of acute ischemic stroke.
Timeline
- Start
- 2025-11-22
- Primary completion
- 2026-10-18
- Completion
- 2026-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KPCXM18 | Unknown | 60 mg | Intravenous |
| Subject | KPCXM18 | Unknown | 100 mg | Intravenous |